Greineder, Colin F <br/><br/>
Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor.  [electronic resource] 

 -  PloS one  2013 
 - e80110 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0080110  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Lung Injury--immunology<br/>Animals<br/>Antigens, CD--immunology<br/>Cell Line<br/>Endothelial Cells--cytology<br/>Endothelial Protein C Receptor<br/>Endothelium, Vascular--drug effects<br/>Humans<br/>Immunoconjugates--chemistry<br/>Intercellular Adhesion Molecule-1--immunology<br/>Intercellular Junctions--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Molecular Targeted Therapy<br/>Platelet Endothelial Cell Adhesion Molecule-1--immunology<br/>Protein C--agonists<br/>Receptors, Cell Surface--immunology<br/>Single-Chain Antibodies--chemistry<br/>Thrombomodulin--chemistry